# Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients

> **NCT01219959** · PHASE3 · COMPLETED · sponsor: **Vantive Health LLC** · enrollment: 71 (actual)

## Conditions studied

- End Stage Renal Disease (ESRD)
- Diabetes
- CAPD

## Interventions

- **DRUG:** Dianeal
- **DRUG:** Dianeal, Extraneal, Nutrineal

## Key facts

- **NCT ID:** NCT01219959
- **Lead sponsor:** Vantive Health LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2025-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01219959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01219959, "Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01219959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*